340B Insight Podcast
340B Insight is 340B Health’s podcast, providing our members and supporters with timely news updates and discussion around the 340B drug pricing program. The podcast enables listeners to stay current and expand their knowledge of 340B to help them serve their patients and communities and remain compliant with rules and requirements. New episodes are published twice per month and include news update segments and in-depth interviews with leading experts including health care practitioners, policy and legal experts, public policymakers, and our expert staff.
Have a question or suggestion for 340B Insight? Email us at: podcast@340bhealth.org
Podcast sponsorship opportunities are available. Email to learn more: robin.hayes@340bhealth.org
Follow 340B Health on Twitter, Facebook, and LinkedIn
Episodes
-
Episode 39: Diabetes Month and 340B
November is American Diabetes Month. To explore how 340B supports care for patients living with diabetes, we speak with Salem Health’s Riley Protz, pharmacy inventory and 340B program manager, and AJ Sowles, manager of ambulatory care clinical pharmacy services. Riley and AJ discuss Salem Health’s use of 340B savings to create a medication management clinic that is helping improve the health outcomes of patients living with diabetes. Before the interview, we share exciting news about 340B Insight, recap several recent federal court decisions in the 340B community pharmacy dispute, and provide an update on Medicare payment cuts to 340B hospitals in 2022. (Transcript)
Read more -
Episode 38: A Patient’s Perspective on 340B
Nov. 4, 2021, is the 29th anniversary of the 340B drug pricing program. To celebrate how 340B has benefited patients, we are joined by Jennifer Gallagher, lead pharmacy technician at Parkview Medical Center in Pueblo, Colo. Jennifer is not only a provider, she also is a patient whose health care journey has repeatedly intersected with the 340B program. She shares her story of how the 340B program has provided her access to the care she has needed to manage multiple health challenges. Before the interview, we answer a listener's question about HRSA audits of drug companies participating in 340B. (Transcript)
Read more -
Episode 37: Responding to the COVID-19 Delta Variant
This week, we are joined again by Scott Milner, senior director of pharmacy, business development, purchasing, 340B, and infusion services at St. Luke’s Health System in Idaho. We had spoken with Scott in January about the initial distribution of COVID-19 vaccines, and we reconnected with him to hear about how St. Luke’s has responded to a recent surge in COVID cases from the Delta variant and its effect on 340B program management. (Transcript)
Read more -
Episode 36: 340B Child Site Registration
This week, we are joined by Amanda Nagrotsky, 340B Health’s legal counsel. 340B child sites are a key component of how hospitals reach more patients and provide more health care services. Amanda discusses what hospitals need to know about registering child sites, including eligibility requirements, registration timelines, required documents, and available resources to help them navigate the process. Before the interview, we provide an update on the Health Resources & Services Administration (HRSA) initiating enforcement actions against another drug company that has stopped providing 340B discounts when drugs are dispensed at community pharmacies. (Transcript)
Read moreThis Episode is Sponsored By
-
Episode 35: HRSA Takes New Action Against Drug Companies Denying 340B Discounts
This week, we are joined by Maureen Testoni, 340B Health’s president and CEO. The Health Resources & Services Administration (HRSA) made a major announcement recently regarding drug companies that are denying 340B discounts on drugs dispensed at community pharmacies. Maureen analyzes the news and discusses what comes next on this issue. She also catches us up on several other important 340B developments from during the summer. (Transcript)
Read moreThis Episode is Sponsored By
-
Episode 34: Telehealth for 340B Hospitals
This week, we are joined by Sumona Das Gupta, assistant director of pharmacy audit and compliance at University of Washington Medical Center and Harborview Medical Center. As part of the UW Medicine health system, the hospitals operate in the first region of the U.S. that experienced community transmission of COVID-19 last year. Sumona discusses how her hospitals quickly expanded their telehealth capacity to serve patients, how this transformation impacted their 340B program operations and compliance, and the benefits telehealth brings to both patients and providers. (Transcript)
Read more